You Are Here: Deltex Medical > Investor Relations > AIM Rule 26
AIM Rule 26

AIM Rule 26

This information was last updated on 8 May 2017.

Where guidance is given to see another section of the website, please click on the highlighted word.

A description of the business:

See Business Description section.

The names of its directors and brief biographical details of each:

See Directors section.

Description of the responsibilities of the members of the board of directors and details of any committees of the board of directors and their responsibilities:

See Board Committees  section.

Its country of incorporation and main country of operation:

Deltex Medical Group plc is incorporated in England and Wales (Registration Number 3902895) which is also its main country of operation. Deltex Medical Group plc is traded on the UK AIM market only.

Its current constitutional documents (e.g. its Articles of Association):

The number of AIM securities in issue (noting any held as treasury shares) and, insofar as it is aware, the percentage of AIM securities that is not in public hands together with the identity and percentage holdings of its significant shareholders.

Please see share information

Details of any restrictions on the transfer of its AIM securities:

Not applicable

UK City Code on Takeovers and Mergers:

The Company is subject to the provisions of the UK City Code on Takeovers and Mergers.

Principles of Corporate Governance;

The Board recognises the importance of sound corporate governance. The company currently does not follow a specific corporate governance code. The Directors have implemented corporate governance procedures and established committees of the Board, including audit and remuneration committees, which they believe are appropriate for the Company’s size.

The company considers all Non-Executive Directors are independent.

Modern slavery encompasses slavery, servitude, human trafficking and forced labour. Deltex Medical Limited has a zero tolerance approach to any form of modern slavery. We are committed to acting ethically and with integrity and transparency in all business dealings.

For copies of the annual and interim reports please see Annual & Interim Reports section.

For all notifications made in the past 12 months please see News Releases section.

For most recent admission document together with any circulars or similar publications sent to shareholders within the past 12 months: